Skip to main content
. 2021 Nov 8;7(4):00254-2021. doi: 10.1183/23120541.00254-2021

FIGURE 1.

FIGURE 1

Prevalence of antinuclear antibody (ANA) seropositivity in interstitial lung disease patients with inhalational exposures.